(Q39471681)

12 September 2017

1 reference

title

Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience (English)

1 reference

12 September 2017

1 reference

1 reference

Hans-Christoph Diener

4

object named as

H C Diener

1 reference

12 September 2017

M Wilkinson

1

1 reference

12 September 2017

V Pfaffenrath

2

1 reference

12 September 2017

J Schoenen

3

1 reference

12 September 2017

T J Steiner

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

12 September 2017

1 reference

12 September 2017

volume

15

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

337-357

1 reference

Treatment of the acute migraine attack--current status.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

A review of current drugs for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Neuromagnetic fields in migraine: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

The visceral organ brain: implications for the pathophysiology of vascular head pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

SUMATRIPTAN: a receptor-targeted treatment for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Focal headache during balloon inflation in the internal carotid and middle cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

On serotonin and migraine: a clinical and pharmacological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Spreading oligemia in the migraine aura--most likely an artifact due to scattered radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

MRI of intracranial arteries in nitroglycerin induced cluster headache attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Cluster headache: evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

5-HT1-like receptor agonists and the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

A proposed new nomenclature for 5-HT receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Long term use of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Sumatriptan is a Potent Vasoconstrictor of Human Dural Arteries Via a 5-HT1-Like Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Lack of antinociceptive activity of sumatriptan in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Lack of an interaction between propranolol and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Efficacy of subcutaneous sumatriptan in repeated episodes of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Oral sumatriptan compared with placebo in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

The safety and tolerability of sumatriptan: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Cardiorespiratory distress after sumatriptan given by injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Coronary vasospasm and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Coronary vasospasm induced by subcutaneous sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Transmural myocardial infarction with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Subcutaneous sumatriptan during the migraine aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Psychoactivity and abuse potential of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Is there a problem with long-term use of sumatriptan in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Sumatriptan in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Pharmacology of antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Cerebral manifestations of ergotism. Report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Angina pectoris and sudden death in the absence of atherosclerosis following ergotamine therapy for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Coronary vasospasm and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Peripheral ischemia secondary to ergotamine intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Myocardial ischaemia in migraine sufferers taking ergotamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Cluster headache. Local anesthetic abortive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Cocaine as an abortive agent in cluster headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Treatment of Acute Cluster Headache with Sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Letter: Ergotamine-induced headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Analgesic-induced chronic headache: long-term results of withdrawal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

Oral sumatriptan in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1995.1505337.X

10.1046/J.1468-2982.1995.1505337.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference